Nexium Iv en es it fr

Nexium Iv Brand names, Nexium Iv Analogs

Nexium Iv Brand Names Mixture

  • No information avaliable

Nexium Iv Chemical_Formula


Nexium Iv RX_link

Nexium Iv fda sheet

Nexium_Iv FDA

Nexium Iv msds (material safety sheet)

Nexium Iv Synthesis Reference

No information avaliable

Nexium Iv Molecular Weight

345.417 g/mol

Nexium Iv Melting Point

155 oC

Nexium Iv H2O Solubility

Very slightly soluble in water

Nexium Iv State


Nexium Iv LogP


Nexium Iv Dosage Forms

Tablet (delayed-release); Delayed-release capsules; IV injection solution; IV iufusion solution

Nexium Iv Indication

For the treatment of acid-reflux disorders (GERD) and peptic ulcer disease

Nexium Iv Pharmacology

Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and H. pylori eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the gastric mucosa, Esomeprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.

Nexium Iv Absorption


Nexium Iv side effects and Toxicity

Blurred vision, confusion, drowsiness, dry mouthflushingheadache, nausea, rapid heartbeat, sweating

Nexium Iv Patient Information

No information avaliable

Nexium Iv Organisms Affected

Humans and other mammals